Con-way UPGRADED to Outperform and 4 Analyst-Upgraded Shares to Remember
Wall St. Watchdog reveals information about companies for which stock analysts upgraded the shares on July 30th. Dendreon (NASDAQ:DNDN): Maxim Group upgraded its rating on this company from Sell to...
View ArticleAffymax EXPECTED to Pass Q3 Estimates and 1 Stock Analysis Not to Miss
Affymax, Inc.’s (NASDAQ:AFFY) partner Fresenius stated that it intends to dose more patients than predicted with Affymax’s Omontys. Rodman & Renshaw think that Affymax could exceed the firm’s Q3...
View ArticleStarbucks POISED for Long-Term Growth and 4 Stock Analyses to Eye
Watson Pharmaceuticals Inc. (NYSE:WPI) estimates were increased by Credit Suisse after a management meeting, and the firm stated that the company has growth drivers beyond 2013 as well as possible...
View ArticleGilead ADDED to Short-Term Buy List and 4 Stock Analyses Trending Now
Camden Property Trust (NYSE:CPT): UBS claims that Camden Property’s pullback is overdone, and it keeps its Buy rating because of strong demand, higher than average job growth within its core markets,...
View ArticleCon-Way Facing Slowdown Risks and 4 Stock Analyses Buzzing on The Street
Zumiez, Inc. (NASDAQ:ZUMZ): Following a strong start to the month, William Blair lowered their September same store sales estimate for Zumiez, Inc. to up 1%-2% from 4% as they believe that the...
View ArticleSaia Initiated at Hold and 4 Analyst-Initiated Shares to Track
Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage on October 5th. LCA Vision (NASDAQ:LCAV): WallachBeth initiated coverage of this company with a rating...
View ArticleAnalyst Keeps Gilead Sciences a Buy and 3 and Stock Analyses Buzzing Now
Charles River Laboratories International, Inc. (NYSE:CRL): Sterne Agee claims that it has confirmed various times that Charles River Labs won a large GLP toxicology partnership with a large pharma...
View Article
